CSL Ltd. (CSLLY)
34.76
+0.12
(+0.35%)
USD |
OTCM |
Oct 28, 16:00
CSL Market Cap : 66.59B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 66.59B |
| October 27, 2026 | 66.36B |
| October 26, 2026 | 65.44B |
| October 23, 2026 | 66.28B |
| October 22, 2026 | 65.90B |
| October 21, 2026 | 65.67B |
| October 20, 2026 | 66.07B |
| October 19, 2026 | 64.37B |
| October 16, 2026 | 63.89B |
| October 15, 2026 | 62.45B |
| October 14, 2026 | 61.82B |
| October 13, 2026 | 61.63B |
| October 12, 2026 | 61.70B |
| October 09, 2026 | 61.70B |
| October 08, 2026 | 60.39B |
| October 07, 2026 | 60.36B |
| October 06, 2026 | 59.71B |
| October 05, 2026 | 59.23B |
| October 02, 2026 | 58.50B |
| October 01, 2026 | 59.27B |
| September 30, 2026 | 61.19B |
| September 29, 2026 | 61.13B |
| September 28, 2026 | 61.30B |
| September 25, 2026 | 59.71B |
| September 24, 2026 | 60.23B |
| Date | Value |
|---|---|
| September 23, 2026 | 59.96B |
| September 22, 2026 | 61.65B |
| September 21, 2026 | 61.13B |
| September 18, 2026 | 59.58B |
| September 17, 2026 | 60.78B |
| September 16, 2026 | 59.00B |
| September 15, 2026 | 60.66B |
| September 14, 2026 | 58.85B |
| September 11, 2026 | 57.30B |
| September 10, 2026 | 57.78B |
| September 09, 2026 | 59.39B |
| September 08, 2026 | 60.44B |
| September 04, 2026 | 60.55B |
| September 03, 2026 | 60.73B |
| September 02, 2026 | 59.96B |
| September 01, 2026 | 58.68B |
| August 31, 2026 | 58.54B |
| August 28, 2026 | 59.23B |
| August 27, 2026 | 60.04B |
| August 26, 2026 | 59.39B |
| August 25, 2026 | 60.07B |
| August 24, 2026 | 57.66B |
| August 21, 2026 | 57.97B |
| August 20, 2026 | 58.31B |
| August 19, 2026 | 57.07B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 24.46M |
| Ceryvyn Therapeutics Ltd. | 3.95M |
| Propanc Biopharma, Inc. | 6.986M |
| Mesoblast Ltd. | 1.736B |
| Actinogen Medical Ltd. | 96.77M |
Market Cap Related Metrics
| PS Ratio | 4.263 |
| Price to Free Cash Flow | 29.92 |
| Price | 34.76 |
| Earnings Yield | -3.90% |
| Operating PE Ratio | 16.74 |
| Normalized PE Ratio | 23.39 |